CTLA-4 checkpoint inhibitor (Anaeropharma Science)

N/A

Report date: 2025/03/18 18:12:46

Base Information

Drug NameCTLA-4 checkpoint inhibitor (Anaeropharma Science)
Drug Alias Nameanti-CTLA4 antibody (Anaeropharma Science)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnaeropharma Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnaeropharma Science Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A